Elsevier

Trials in Vaccinology Template

Write in a clean editor, then format for Trials in Vaccinology in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Trials in Vaccinology format

Trials in Vaccinology is a peer-reviewed journal published by Elsevier, covering Viral gastroenteritis research and epidemiology, Influenza Virus Research Studies, Viral Infections and Immunology Research.

PublisherElsevier
Reference styleNumbered (Elsevier)
Numbered — [1], [2] in the text
[1] A. Smith, B. Jones, C. Lee, A representative article title, Trials in Vaccinology 12 (2023) 45–58.

Formats any DOI in Trials in Vaccinology style. No sign-up.

Publishes research inViral gastroenteritis research and epidemiology Influenza Virus Research Studies Viral Infections and Immunology Research Virus-based gene therapy research Respiratory viral infections research
ISSN1879-4378
h-index18
i10-index43
Total citations1,153
Top institutions publishing hereZoetis (United States)
Journal websitewww.sciencedirect.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Trials in Vaccinology per year

11
2012
16
2013
23
2014
17
2015
14
2016

Citation impact of Trials in Vaccinology by publication year

49
2012
215
2013
263
2014
173
2015
449
2016

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Trials in Vaccinology

B-cell epitope mapping for the design of vaccines and effective diagnostics

Tarek A. Ahmad, Amrou E. Eweida, Salah A. Sheweita · 1 Jan 2016

The increasing resistance of many microbial strains to antibiotics, delayed laboratory results, and side effects of many chemotherapeutics has raised the need to search for sensitive diagnostics and new prophylactic strategies especially prevention by vaccination. Understanding the epitope/antibody interaction is the key to constructing potent vaccines and effective diagnostics. B-cell epitope mapping is a promising…

A post hoc assessment of duration of protection in CAPiTA (Community Acquired Pneumonia immunization Trial in Adults)

Scott D. Patterson, Chris Webber, Michael A. Patton et al. · 1 Jan 2016

The Community Acquired Pneumonia immunization Trial in Adults (CAPiTA) was conducted to evaluate 13-valent pneumococcal conjugate vaccine (PCV13) for the prevention of vaccine-type community-acquired pneumonia (VT-CAP) and vaccine-type invasive pneumococcal disease (VT-IPD) in adults aged ⩾65 years. Plotting the cumulative number of episodes against time from vaccination demonstrated that efficacy was evident soon after vaccination…

Development of immunization trials against Eimeria spp.

Tarek A. Ahmad, Bassant A. El-Sayed, Laila El‐Sayed · 1 Jan 2016

Coccidiosis is a major intestinal disease affecting economically valuable livestock animals such as chickens and turkeys. Economic losses are associated with decreased productivity in afflicted animals. The different Eimeria spp. are the main etiologic agents for that virulent disease. The usefulness of prophylactic and therapeutic anticoccidial compounds has decreased in recent years due to the…

Development of immunization trials against Acinetobacter baumannii

Tarek A. Ahmad, Dina M. Tawfik, Salah A. Sheweita et al. · 1 Jan 2016

Acinetobacter baumannii has recently crossed all lines once considered harmless, pushing its way as a nosocomial pathogen. It had acquired resistance to almost all available chemotherapies and mainly targets intensive care residents; causing pneumonia and major outbreaks with high mortality rates. This urged the need for preventive methods, which include infection control, non-specific immune-therapy, passive,…

Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines

Daniel H. Libraty, Lei Zhang, Marcia Woda et al. · 14 Dec 2013

Neonatal Bacille Calmette Guérin (BCG) vaccination has been reported to have beneficial effects beyond preventing infantile tuberculous meningitis and miliary disease. We hypothesized that BCG vaccine given at birth would enhance T-helper 1 (Th1) immune responses to the first vaccines given later in infancy. We conducted a nested case-control study of neonatal BCG vaccination and…

Trials in Vaccinology template — frequently asked questions

How do I write a paper in the Trials in Vaccinology format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Trials in Vaccinology template. When you export, DocuGuru compiles the paper into the official Elsevier format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Trials in Vaccinology use?
Trials in Vaccinology uses Numbered (Elsevier) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: [1] A. Smith, B. Jones, C. Lee, A representative article title, Trials in Vaccinology 12 (2023) 45–58.
Do I need to know LaTeX to submit to Trials in Vaccinology?
No. DocuGuru generates the elsarticle LaTeX class and compiles the PDF for you in the background, so you get a Elsevier-ready Trials in Vaccinology document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Trials in Vaccinology template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Trials in Vaccinology format with correct headings, figures, tables, and numbered citations.
Who publishes Trials in Vaccinology?
Trials in Vaccinology is a multidisciplinary journal published by Elsevier. DocuGuru's Trials in Vaccinology template matches Elsevier's official submission format.
Can I export a submission-ready Trials in Vaccinology PDF?
Yes — DocuGuru produces a PDF built with the official Trials in Vaccinology template (the elsarticle class) that is ready to submit to Elsevier, together with the matching LaTeX source files.
How much does the Trials in Vaccinology template cost?
You can start writing in the Trials in Vaccinology template for free. Exporting the final submission-ready Trials in Vaccinology PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Trials in Vaccinology template